ClinicalTrials.gg
Drug

Liposomal Cytarabine clinical trials

A product of Cytarabine; its studies count on that page too.

studies test it
19
open now
0
in phase 3
5
first study started
1996

How each study uses Liposomal Cytarabine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
1 Apr 1999 · DEPOCYT · NDA 021041 (FDA, Drugs@FDA)
European Union
11 Jul 2001 · DepoCyte · EMEA/H/C/000317 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

liposomal cytarabine
11
Depocyte
8
DepoCyt
7
cytarabine liposome injection
2

Development codes

DTC 101
1

Studies by the year they started

19 studies that test it; most in 2009 (4)

Studies that test Liposomal Cytarabine, by start year
YearStudies
19961
19971
20031
20041
20063
20071
20081
20094
20113
20122
20141

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
11
Phase 3
5
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 1 · Other 18

Goethe University (2) · PETHEMA Foundation (2) · International Extranodal Lymphoma Study Group (IELSG) (1) · Andrés José Maria Ferreri (1) · Nordic Lymphoma Group (1) · Centre Oscar Lambret (1) · University of Washington (1) · Northern Italy Leukemia Group (1)

Often tested with

Tested in the same studies.

Methotrexate (4) · Cyclophosphamide (3) · Vincristine (3) · Rituximab (2) · Prednisolone (2) · Dexamethasone (2) · Mercaptopurine (2) · Asparaginase (2)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses Liposomal Cytarabine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 19

Given beside what is tested · 3 — Liposomal Cytarabine is usual care or a partner of the new treatment